Anna Clara Randag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anna Clara Randag has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Barbara Schimmer
National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands
3 shared publications - Jeroen van Rooij
Rotterdam Eye Hospital Rotterdam The Netherlands
3 shared publications Cathrien A. Eggink
Dutch Cornea Society of the Dutch Ophthalmological Society Nijmegen The Netherlands
2 shared publications- Foekje Francina Stelma
Department of Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
2 shared publications Henny Otten
Visser Contactlenzen Nijmegen The Netherlands
2 shared publications- Robert P. L. Wisse
University Medical Center, Utrecht, The Netherlands
2 shared publications
Latest Publications
- 2 July 2026
- Published by Wiley in Acta Ophthalmologica
Risk factors for acquisition and severity of Acanthamoeba and Fusarium keratitis in contact lens users—A case–control and clinical–epidemiological study, 2009–2020
Purpose: Since 2015, the uncommon yet severe Acanthamoeba keratitis (AK) and Fusarium keratitis (FK) have increased in the Netherlands, predominantly in contact lens (CL) users. We investigated risk factors for acquisition and severity of AK and FK among CL users. Methods: For this retrospective case–control study, we approached AK and FK cases diagnosed in 16 cornea reference centres between 2009 and 2019. CL‐wearing controls were recruited in 2020 through social media. Besides, we assessed risk factors for treatment failure (corneal transplantation and/or final visual acuity ≤0.25) among cases included in the case–control study. Odds ratios (OR) with 95% confidence intervals (95%CI) were computed in multivariable logistic regression analyses. Results: The case–control study comprised 220 cases (181 AK, 39 FK) and 1020 controls. Identified risk factors were previous eye injury (OR: 16.0, 95%CI: 3.4–76.7), occupational/recreational surface water contact (OR: 9.1, 95%CI: 3.5–23.2), cleaning/rinsing CLs with tap water (OR: 3.3, 95%CI: 1.7–6.4), cigarette smoke exposure (OR: 1.9, 95%CI: 1.1–3.5) and napping in CLs (OR: 1.9, 95%CI: 1.0–3.6). Treatment failure occurred in 85/179 (47%) AK and 23/35 (66%) FK cases. Evisceration or enucleation was performed in 9/179 (5%) AK and 5/35 (14%) FK cases. Age > 42 years (OR: 5.6, 95%CI: 2.3–14.6), hard CL use (OR: 3.3, 95%CI: 1.0–14.0), corticosteroid eye drops prior to diagnosis (OR: 3.8, 95%CI: 1.5–10.5) and a ring infiltrate at diagnosis (OR: 15.3, 95%CI: 4.8–57.4) were associated with AK treatment failure. Conclusion: Identified preventable risks warrant enhanced communication between eye care providers and CL wearers promoting healthy CL wear and care practices. Increased awareness among ophthalmologists is needed to prevent corticosteroid treatment prior to AK diagnosis to reduce treatment failure.
- 2 July 2026
- Published by Wiley in Acta Ophthalmologica
Risk factors for acquisition and severity of Acanthamoeba and Fusarium keratitis in contact lens users—A case–control and clinical–epidemiological study, 2009–2020
Purpose: Since 2015, the uncommon yet severe Acanthamoeba keratitis (AK) and Fusarium keratitis (FK) have increased in the Netherlands, predominantly in contact lens (CL) users. We investigated risk factors for acquisition and severity of AK and FK among CL users. Methods: For this retrospective case–control study, we approached AK and FK cases diagnosed in 16 cornea reference centres between 2009 and 2019. CL‐wearing controls were recruited in 2020 through social media. Besides, we assessed risk factors for treatment failure (corneal transplantation and/or final visual acuity ≤0.25) among cases included in the case–control study. Odds ratios (OR) with 95% confidence intervals (95%CI) were computed in multivariable logistic regression analyses. Results: The case–control study comprised 220 cases (181 AK, 39 FK) and 1020 controls. Identified risk factors were previous eye injury (OR: 16.0, 95%CI: 3.4–76.7), occupational/recreational surface water contact (OR: 9.1, 95%CI: 3.5–23.2), cleaning/rinsing CLs with tap water (OR: 3.3, 95%CI: 1.7–6.4), cigarette smoke exposure (OR: 1.9, 95%CI: 1.1–3.5) and napping in CLs (OR: 1.9, 95%CI: 1.0–3.6). Treatment failure occurred in 85/179 (47%) AK and 23/35 (66%) FK cases. Evisceration or enucleation was performed in 9/179 (5%) AK and 5/35 (14%) FK cases. Age > 42 years (OR: 5.6, 95%CI: 2.3–14.6), hard CL use (OR: 3.3, 95%CI: 1.0–14.0), corticosteroid eye drops prior to diagnosis (OR: 3.8, 95%CI: 1.5–10.5) and a ring infiltrate at diagnosis (OR: 15.3, 95%CI: 4.8–57.4) were associated with AK treatment failure. Conclusion: Identified preventable risks warrant enhanced communication between eye care providers and CL wearers promoting healthy CL wear and care practices. Increased awareness among ophthalmologists is needed to prevent corticosteroid treatment prior to AK diagnosis to reduce treatment failure.
- 5 March 2026
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (11) , 1312-1318
Treatment failure in herpes simplex virus type 1 keratitis
Herpes simplex virus type 1 (HSV-1), one of the human herpesviruses, is a frequent cause of recurrent ocular infections. Treatment primarily relies on nucleoside analogues, such as aciclovir (ACV), with or without topical corticosteroids. Treatment failure may be attributed to non-adherence to therapy or inadequate topical corticosteroid dosing, and to a lesser extent to an incorrect diagnosis, coinfection with non-viral pathogens or therapy resistance. ACV resistance (ACV R ) is relatively rare compared with other reasons for treatment failure, but has been documented in 6% of immunocompetent patients with HSV-1 keratitis. ACV R limits the prophylactic and therapeutic efficacy of nucleoside analogues, potentially leading to clinically refractory disease. In this review, we will address the normal pathogenesis of HSV-1 keratitis, the definition and causes of treatment failure in HSV-1 keratitis, a work-up algorithm to be used in the event of treatment failure, the effect of current treatment regimens on the development of ACV R keratitis and treatment options for ACV R keratitis.
- 5 March 2026
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (11) , 1312-1318
Treatment failure in herpes simplex virus type 1 keratitis
Herpes simplex virus type 1 (HSV-1), one of the human herpesviruses, is a frequent cause of recurrent ocular infections. Treatment primarily relies on nucleoside analogues, such as aciclovir (ACV), with or without topical corticosteroids. Treatment failure may be attributed to non-adherence to therapy or inadequate topical corticosteroid dosing, and to a lesser extent to an incorrect diagnosis, coinfection with non-viral pathogens or therapy resistance. ACV resistance (ACV R ) is relatively rare compared with other reasons for treatment failure, but has been documented in 6% of immunocompetent patients with HSV-1 keratitis. ACV R limits the prophylactic and therapeutic efficacy of nucleoside analogues, potentially leading to clinically refractory disease. In this review, we will address the normal pathogenesis of HSV-1 keratitis, the definition and causes of treatment failure in HSV-1 keratitis, a work-up algorithm to be used in the event of treatment failure, the effect of current treatment regimens on the development of ACV R keratitis and treatment options for ACV R keratitis.
- Open Access
- 1 March 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 1033-1043
Microbial Keratitis Before, During and After the COVID-19 Pandemic, and the Role of Contact Lens Wear and Hand Hygiene
Introduction: During the COVID-19 pandemic, there was a significant decline in the number of patients with both non-urgent and urgent ophthalmologic conditions presenting to emergency departments, leading to concerns about the whereabouts of patients in need of care. We hypothesized that there was an actual decrease in microbial keratitis (MK) cases, due to reduced contact lens (CL) wear and improved hand hygiene, including alcohol-based hand disinfection. Besides, we questioned if non-pharmaceutical interventions would have a sustained effect after the COVID-19 pandemic. Methods: Retrospectively, characteristics of patients presenting with MK at a large ophthalmic tertiary referral center were compared during 9 March– 15 June of 2018 and 2019 (“pre-COVID”), 2020 (“COVID”) and 2022 and 2023 (“post-COVID”). In an online cross-sectional survey among CL wearers, CL wear and hand hygiene habits were compared for the recall months February and April 2020. Results: Three hundred and one MK patients were included: 79 in 2018, 69 in 2019, 41 in 2020, 60 in 2022 and 52 in 2023. Presentation delay was ≥ 4 days in 38% during COVID, compared to 54% pre-COVID (p = 0.106). The proportion of CL related MK did not differ (p = 0.704). Fewer patients were admitted than pre-COVID (p = 0.026), without a difference in admission indications (p = 0.322). Pseudomonas aeruginosa and Staphylococcus aureus cases were not observed during COVID. Post-COVID, MK by Pseudomonas aeruginosa occurred more often than pre-COVID (p < 0.001). In the online survey with 791 respondents, hand washing before CL insertion and removal and hand disinfection were reported more often in April 2020 than February 2020 (respectively, p = 0.001, p < 0.001 and p < 0.001). Conclusion: We found no evidence of MK patients facing barriers to accessing hospital care during the COVID-19 pandemic, as presentation delays were not longer and cases not more severe. Our data suggest that a decreased MK incidence may be due to improved hand hygiene practices, including alcohol-based hand disinfection.
- 1 March 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 1033-1043
Open AccessMicrobial Keratitis Before, During and After the COVID-19 Pandemic, and the Role of Contact Lens Wear and Hand Hygiene
Introduction: During the COVID-19 pandemic, there was a significant decline in the number of patients with both non-urgent and urgent ophthalmologic conditions presenting to emergency departments, leading to concerns about the whereabouts of patients in need of care. We hypothesized that there was an actual decrease in microbial keratitis (MK) cases, due to reduced contact lens (CL) wear and improved hand hygiene, including alcohol-based hand disinfection. Besides, we questioned if non-pharmaceutical interventions would have a sustained effect after the COVID-19 pandemic. Methods: Retrospectively, characteristics of patients presenting with MK at a large ophthalmic tertiary referral center were compared during 9 March– 15 June of 2018 and 2019 (“pre-COVID”), 2020 (“COVID”) and 2022 and 2023 (“post-COVID”). In an online cross-sectional survey among CL wearers, CL wear and hand hygiene habits were compared for the recall months February and April 2020. Results: Three hundred and one MK patients were included: 79 in 2018, 69 in 2019, 41 in 2020, 60 in 2022 and 52 in 2023. Presentation delay was ≥ 4 days in 38% during COVID, compared to 54% pre-COVID (p = 0.106). The proportion of CL related MK did not differ (p = 0.704). Fewer patients were admitted than pre-COVID (p = 0.026), without a difference in admission indications (p = 0.322). Pseudomonas aeruginosa and Staphylococcus aureus cases were not observed during COVID. Post-COVID, MK by Pseudomonas aeruginosa occurred more often than pre-COVID (p < 0.001). In the online survey with 791 respondents, hand washing before CL insertion and removal and hand disinfection were reported more often in April 2020 than February 2020 (respectively, p = 0.001, p < 0.001 and p < 0.001). Conclusion: We found no evidence of MK patients facing barriers to accessing hospital care during the COVID-19 pandemic, as presentation delays were not longer and cases not more severe. Our data suggest that a decreased MK incidence may be due to improved hand hygiene practices, including alcohol-based hand disinfection.
- Open Access
In Vitro Effectiveness of Soft Contact Lens Solutions Available on the Dutch Market against Acanthamoeba Species
Acanthamoeba keratitis is almost universally associated with contact lens (CL) use. Until today, however, CL solution manufacturing protocols lack testing of anti-amoebic activity. This study investigates the effectiveness of CL solutions available on the Dutch market against trophozoites and cysts of Acanthamoeba castellanii and Acanthamoeba polyphaga. Sixteen CL solutions were tested: 13 multiple purpose solutions (MPS), 2 hydrogen peroxidase solutions (HPS) and 1 povidone-iodine-based solution (PIS). The Spearman–Karber (SK) log reduction method and an XTT colorimetric assay were used to evaluate the effectiveness at the manufacturer’s minimum recommended disinfection time (MMRDT) and after eight hours. At the MMRDT, one MPS showed an SK mean log reduction (MLR) of >3.0 against A. castellanii trophozoites. Two additional MPS and both HPS reached this threshold after eight hours. The SK MLR values for A. polyphaga trophozoites were between 1 and 3 at all time points. Using the XTT colorimetric assay, only HPS 1 showed >99.9% reduction (equivalent to 3 log reduction) in metabolic activity of A. castellanii trophozoites after eight hours. For A. polyphaga, both HPS and PIS showed a metabolic reduction of >99.9% after eight hours. Cysts were resistant against all solutions. We conclude that following the manufacturer’s guidelines, few solutions provide sufficient effectiveness against Acanthamoeba trophozoites and none against cysts. The results underline the importance of adequate hygiene when handling CLs.
Open AccessIn Vitro Effectiveness of Soft Contact Lens Solutions Available on the Dutch Market against Acanthamoeba Species
Acanthamoeba keratitis is almost universally associated with contact lens (CL) use. Until today, however, CL solution manufacturing protocols lack testing of anti-amoebic activity. This study investigates the effectiveness of CL solutions available on the Dutch market against trophozoites and cysts of Acanthamoeba castellanii and Acanthamoeba polyphaga. Sixteen CL solutions were tested: 13 multiple purpose solutions (MPS), 2 hydrogen peroxidase solutions (HPS) and 1 povidone-iodine-based solution (PIS). The Spearman–Karber (SK) log reduction method and an XTT colorimetric assay were used to evaluate the effectiveness at the manufacturer’s minimum recommended disinfection time (MMRDT) and after eight hours. At the MMRDT, one MPS showed an SK mean log reduction (MLR) of >3.0 against A. castellanii trophozoites. Two additional MPS and both HPS reached this threshold after eight hours. The SK MLR values for A. polyphaga trophozoites were between 1 and 3 at all time points. Using the XTT colorimetric assay, only HPS 1 showed >99.9% reduction (equivalent to 3 log reduction) in metabolic activity of A. castellanii trophozoites after eight hours. For A. polyphaga, both HPS and PIS showed a metabolic reduction of >99.9% after eight hours. Cysts were resistant against all solutions. We conclude that following the manufacturer’s guidelines, few solutions provide sufficient effectiveness against Acanthamoeba trophozoites and none against cysts. The results underline the importance of adequate hygiene when handling CLs.
- Open Access
- 16 September 2022
- Published by Springer Nature in Research Square
Standardizing the assessment of amoebicidal efficacy of contact lens solutions against Acanthamoeba species
Background To date no standardized methods are used in order to assess the amoebicidal efficacy of commercial contact lens solutions for both trophozoites and cysts of Acanthamoeba species. Here we present two methods that are suitable for this purpose: The Spearman-Karber log reduction method and XTT colorimetric assay. Methods Acanthamoeba castellanii (ATCC 50370) and A. polyphaga (ATCC 30461) trophozoites were cultured in peptone-yeast extract-glucose medium. Cysts were developed in Neff’s encystement medium for 1 week. Spearman-Karber and XTT colorimetric assay were used to evaluate trophozoite and cystocidal efficacy of multi-purpose contact lens solutions (MPS). Results With trophozoites, the Spearman-Karber method gave a log reduction estimate of morphological kill between log 0,83 and log 3,61 of the various contact lens solutions, enabling the differentiation between efficacious and less efficacious solutions. With cysts the maximum log reduction of 2,17 was achieved for all 3 MPS solutions at 8 hours. The XTT colorimetric assay showed reduction in trophozoite metabolic rates between 50 and 100% as provided by an optical density signal. All lens fluid solution with a reduction rate > 90% showed residual growth of Acanthamoeba after one week of incubation on nutrient agar covered with Enterobacter aerogenes. Conclusion Both methods give reproducible estimates of amoebicidal efficacy of contact lens solutions, however, XTT colorimetric assay should be followed by an assay for residual growth to test for viable cysts.
- 16 September 2022
- Published by Springer Nature in Research Square
Open AccessStandardizing the assessment of amoebicidal efficacy of contact lens solutions against Acanthamoeba species
Background To date no standardized methods are used in order to assess the amoebicidal efficacy of commercial contact lens solutions for both trophozoites and cysts of Acanthamoeba species. Here we present two methods that are suitable for this purpose: The Spearman-Karber log reduction method and XTT colorimetric assay. Methods Acanthamoeba castellanii (ATCC 50370) and A. polyphaga (ATCC 30461) trophozoites were cultured in peptone-yeast extract-glucose medium. Cysts were developed in Neff’s encystement medium for 1 week. Spearman-Karber and XTT colorimetric assay were used to evaluate trophozoite and cystocidal efficacy of multi-purpose contact lens solutions (MPS). Results With trophozoites, the Spearman-Karber method gave a log reduction estimate of morphological kill between log 0,83 and log 3,61 of the various contact lens solutions, enabling the differentiation between efficacious and less efficacious solutions. With cysts the maximum log reduction of 2,17 was achieved for all 3 MPS solutions at 8 hours. The XTT colorimetric assay showed reduction in trophozoite metabolic rates between 50 and 100% as provided by an optical density signal. All lens fluid solution with a reduction rate > 90% showed residual growth of Acanthamoeba after one week of incubation on nutrient agar covered with Enterobacter aerogenes. Conclusion Both methods give reproducible estimates of amoebicidal efficacy of contact lens solutions, however, XTT colorimetric assay should be followed by an assay for residual growth to test for viable cysts.
- Open Access
- 6 September 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (9) , e0222092
The rising incidence of Acanthamoeba keratitis: A 7-year nationwide survey and clinical assessment of risk factors and functional outcomes
To evaluate the incidence of Acanthamoeba keratitis in the Netherlands between 2009 and 2015 and to analyse predicting factors for treatment outcome. Patient characteristics, diagnostic methods, diagnostic delay, therapy prior to and after diagnosis, and visual outcome were obtained from medical files of all patients diagnosed with Acanthamoeba keratitis in the Netherlands between 2009 and 2015. A logistic regression analysis on treatment failure, defined as a best corrected visual acuity of less than 20/40 Snellen decimals (i.e. >0.3 logMAR or an approximate loss of three lines of visual acuity) and/or the need for keratoplasty, was performed to determine predicting factors. Two hundred and twenty-four eyes of 224 patients were included. Ninety-five percent of the patients were contact lens wearers, of whom 74% wore soft contact lenses. The number of cases increased from 16 in 2009 to 49 in 2015. This resulted in an estimated incidence of 1 in 21,000 for soft contact lens wearers in 2015. Eighty-seven eyes (39%) met the criteria for treatment failure. In a multivariable regression analysis, higher age at presentation, a higher severity stage and corticosteroid use before diagnosis were positively correlated with treatment failure. Early referral to a cornea specialist was associated with better clinical outcomes. Although Acanthamoeba keratitis is still a relatively uncommon disease, the incidence in soft contact lens wearers has increased to reach 1 in 21,000 in 2015. Treatment failure occurred in 39% of cases, with age, higher severity stage, corticosteroid use before diagnosis and indirect referral to a cornea specialist as important risks factors.
- 6 September 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (9) , e0222092
Open AccessThe rising incidence of Acanthamoeba keratitis: A 7-year nationwide survey and clinical assessment of risk factors and functional outcomes
To evaluate the incidence of Acanthamoeba keratitis in the Netherlands between 2009 and 2015 and to analyse predicting factors for treatment outcome. Patient characteristics, diagnostic methods, diagnostic delay, therapy prior to and after diagnosis, and visual outcome were obtained from medical files of all patients diagnosed with Acanthamoeba keratitis in the Netherlands between 2009 and 2015. A logistic regression analysis on treatment failure, defined as a best corrected visual acuity of less than 20/40 Snellen decimals (i.e. >0.3 logMAR or an approximate loss of three lines of visual acuity) and/or the need for keratoplasty, was performed to determine predicting factors. Two hundred and twenty-four eyes of 224 patients were included. Ninety-five percent of the patients were contact lens wearers, of whom 74% wore soft contact lenses. The number of cases increased from 16 in 2009 to 49 in 2015. This resulted in an estimated incidence of 1 in 21,000 for soft contact lens wearers in 2015. Eighty-seven eyes (39%) met the criteria for treatment failure. In a multivariable regression analysis, higher age at presentation, a higher severity stage and corticosteroid use before diagnosis were positively correlated with treatment failure. Early referral to a cornea specialist was associated with better clinical outcomes. Although Acanthamoeba keratitis is still a relatively uncommon disease, the incidence in soft contact lens wearers has increased to reach 1 in 21,000 in 2015. Treatment failure occurred in 39% of cases, with age, higher severity stage, corticosteroid use before diagnosis and indirect referral to a cornea specialist as important risks factors.